Effects of RT234 on Exercise Parameters Accessed by CPET in Subjects With PAH

Condition:   Pulmonary Arterial Hypertension Intervention:   Combination Product: Drug: RT234 - vardenafil inhalation powder; Device: Axially Oscillating Sphere dry powder inhaler (AOS DPI) Sponsors:   Respira Therapeutics, Inc.;   Argint International;   Precision For Medicine Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials